drugset / Trial / NCT04155008

Nutrition and Pharmacological Algorithm for Oncology Patients Study

NCT04155008

Phase 4 Terminated 1 enrolled Montefiore Medical Center
Non-randomizedParallel-groupOpen-labelSupportive care

Summary

Loss of appetite is a common symptom of patients with cancer and can cause distress which impacts patients and caregivers. Patients diagnosed with head/neck, lung or pancreatic cancer will be recruited for this study to decrease the suffering and distress associated with eating during cancer treatment and improve the quality of life of patients by implementing an algorithm utilizing nutrition intervention and appetite stimulants.

Timeline

Start
2021-03-01
Primary completion
2021-04-05
Completion
2021-04-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 4 mg Oral
Subject Dronabinol Other / unclassified 2.5 mg
Subject Mirtazapine Other / unclassified 7.5 mg Oral
Subject Mirtazapine Other / unclassified 15 mg Oral